Opportunity Information: Apply for W81XWH 21 GWIRP IA
The DoD Gulf War Illness Research Program (GWIRP) FY21 Idea Award is a research grant opportunity designed to spark brand-new, early-stage ideas that could eventually lead to meaningful biomarkers (markers) or treatments for Gulf War Illness (GWI) affecting Veterans of the 1990-1991 Gulf War. It is specifically aimed at the Discovery phase of the research pipeline, meaning the program is looking for projects that are still in the formative stages but have a strong scientific rationale and clear potential to open up new directions for the field. The emphasis is on innovation and creativity, including high-risk/high-reward approaches that may challenge existing thinking, introduce a new framework for understanding GWI, or apply fresh perspectives to long-standing problems. Multidisciplinary projects are especially encouraged, reflecting the reality that GWI symptoms cut across many biological systems and often require expertise from multiple fields to study effectively.
A notable feature of this award is that preliminary data are not required. The program is structured to lower the barrier for proposing bold concepts that might not yet have extensive supporting datasets. If applicants do include unpublished preliminary results, those data are expected to come from the principal investigator or the project team. Even without preliminary data, proposals must still be grounded in a sound scientific rationale, supported by logical reasoning and/or a strong, critical review of existing research literature. In other words, the program is willing to fund early ideas, but it still expects the underlying reasoning to be credible and well-supported.
The program also places a strong requirement on impact. Every application must clearly explain how the expected results could lead to clinical benefit for Veterans with GWI, even if the work itself will not immediately produce a clinical tool or therapy. The focus must remain explicitly on Gulf War Illness and the population of Veterans from the 1990-1991 Gulf War affected by GWI. Applicants are expected to make the case, in plain terms, for how their project could matter to GWI specifically, rather than broadly addressing related conditions without a direct connection.
While applicants can propose work in any GWI-relevant area aligned with the program mission, the FY21 Idea Award highlights several areas of special interest. These include identifying treatments for GWI, especially approaches that already show signs of benefit, and identifying causes and treatment targets tied to dysregulated biological systems. The announcement lists a wide range of symptom and system domains that are of interest, such as cognitive and mood-related difficulties (including memory deficits and behavior disturbances), non-restorative sleep and sleep disorders, chronic widespread pain, chronic debilitating fatigue, gastrointestinal issues (including dietary intolerances, GERD, and functional GI disorders), sinus and respiratory effects, headaches, dermatological problems, neurological dysfunction (central, peripheral, autonomic, and neuromuscular), immune dysfunction, and endocrine/exocrine/excretory dysfunction with particular attention to kidney and liver pathways (including cytochrome P450 abnormalities). It also encourages research on microbiome variants, how stressors like exertion or immune challenge influence symptom severity and duration, and how dysfunctional "crosstalk" between systems (for example, immune changes affecting the nervous system, or autonomic dysfunction disrupting GI function) can drive multi-system illness. Additional emphasized directions include identifying molecular signatures (genomic, proteomic, metabolic, epigenetic) that may explain symptoms and help subgroup patients by underlying biology, studying comorbidities and differences by sex or ethnicity, evaluating whether GWI changes outcomes for other infections or diseases, and developing treatments or biomarkers tailored to specific GWI subtypes.
The opportunity also includes an optional Biorepository Contribution pathway tied to the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) for GWI, which was created to retain and share biospecimens and data from Gulf War Veterans for research use. Applicants are encouraged to contribute relevant Veteran biospecimens and/or data to this network, and those who apply under the Biorepository Contribution Option can request slightly higher funding. This option comes with extra submission requirements (including a specific biorepository contribution statement) and is intended to strengthen shared research infrastructure and improve the long-term value of funded projects for the broader GWI research community.
Several activities are explicitly not supported. The program will not fund studies that treat psychiatric disease or psychological stress as the primary cause of GWI. It also does not support applications focused on amyotrophic lateral sclerosis (ALS) as the central topic, although Gulf War Veterans with ALS may be included if ALS is part of the study's GWI case definition and the work is still fundamentally about GWI symptomatology. In addition, clinical trials are not allowed under this mechanism. For this program, a clinical trial is defined as prospective assignment of human subjects to interventions (including placebo or controls) to evaluate effects on health outcomes. Researchers who want to run clinical trials are directed to other GWIRP funding mechanisms designed for that purpose, such as the Clinical Evaluation Award or Therapeutic/Biomarker Trial Award.
From an administrative standpoint, awards are issued as federal assistance agreements, meaning they can be either grants or cooperative agreements depending on how much involvement the Department of Defense expects to have during the project. If the agency anticipates no substantial involvement, a standard grant is used; if substantial involvement is expected (such as collaboration or participation in aspects of the research), a cooperative agreement is used, and the specific involvement is spelled out in the award terms. The funding limit for the Idea Award is capped at $200,000 in direct costs for the full period of performance, or up to $220,000 in direct costs if using the Biorepository Contribution Option. The program anticipated making about one award, with an estimated total allotment of about $0.32 million, and awards were expected to be made by September 30, 2022. Eligibility is listed as unrestricted (open to any entity type, subject to any additional eligibility notes in the full announcement). The opportunity was administered by the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA), under funding opportunity number W81XWH-21-GWIRP-IA, with the original application closing date of August 19, 2021.Apply for W81XWH 21 GWIRP IA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness, Idea Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Mar 11, 2021.
- Applicants must submit their applications by Aug 19, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
DoD Gulf War Illness Research Program (GWIRP) FY21 Idea Award - FAQs
What is the GWIRP FY21 Idea Award?
The DoD Gulf War Illness Research Program (GWIRP) FY21 Idea Award is a research grant opportunity intended to spark brand-new, early-stage research ideas that could eventually lead to meaningful biomarkers (markers) or treatments for Gulf War Illness (GWI) affecting Veterans of the 1990-1991 Gulf War.
What stage of research is this award meant to support?
This award is aimed at the Discovery phase of the research pipeline. It supports projects that are still formative but have a strong scientific rationale and clear potential to open new directions for the GWI field.
What is the main emphasis of the Idea Award?
The emphasis is on innovation and creativity, including high-risk/high-reward approaches. The program is interested in ideas that may challenge existing thinking, introduce new frameworks for understanding GWI, or apply fresh perspectives to long-standing problems.
Are multidisciplinary projects encouraged?
Yes. Multidisciplinary projects are especially encouraged, reflecting that GWI symptoms span many biological systems and often require expertise across multiple fields.
Is preliminary data required to apply?
No. Preliminary data are not required for this award. The mechanism is designed to lower the barrier to proposing bold concepts that may not yet have extensive supporting datasets.
If preliminary data are included, are there restrictions?
Yes. If applicants include unpublished preliminary results, those data are expected to come from the principal investigator or the project team.
How can an application be competitive without preliminary data?
Even without preliminary data, proposals must be grounded in a sound scientific rationale. Applications should support their approach using logical reasoning and/or a strong, critical review of existing research literature.
What impact must applicants describe?
Every application must clearly explain how the expected results could lead to clinical benefit for Veterans with GWI, even if the proposed work itself will not immediately produce a clinical tool or therapy.
Does the project need to be explicitly about Gulf War Illness?
Yes. The focus must remain explicitly on Gulf War Illness and the population of Veterans from the 1990-1991 Gulf War affected by GWI. Applicants are expected to explain, in plain terms, how the project matters to GWI specifically rather than only broadly addressing related conditions.
Are there specific research areas highlighted as special interests?
Yes. While any GWI-relevant area aligned with the program mission may be proposed, the FY21 Idea Award highlights areas of special interest, including identifying treatments for GWI (especially approaches that already show signs of benefit) and identifying causes and treatment targets tied to dysregulated biological systems.
What symptom domains and body systems are of interest to the program?
The announcement indicates interest across a wide range of symptom and system domains, including cognitive and mood-related difficulties (such as memory deficits and behavior disturbances), non-restorative sleep and sleep disorders, chronic widespread pain, chronic debilitating fatigue, gastrointestinal issues (including dietary intolerances, GERD, and functional GI disorders), sinus and respiratory effects, headaches, dermatological problems, neurological dysfunction (central, peripheral, autonomic, and neuromuscular), immune dysfunction, and endocrine/exocrine/excretory dysfunction with particular attention to kidney and liver pathways (including cytochrome P450 abnormalities).
Does the program encourage microbiome research?
Yes. Research on microbiome variants is specifically encouraged as one of the emphasized directions.
Are studies on symptom triggers or stressors relevant?
Yes. The program encourages research on how stressors such as exertion or immune challenge influence symptom severity and duration.
Is research on interactions between biological systems encouraged?
Yes. The opportunity emphasizes studying dysfunctional "crosstalk" between systems, such as immune changes affecting the nervous system or autonomic dysfunction disrupting gastrointestinal function, as potential drivers of multi-system illness.
What kinds of biomarker or molecular signature work does the announcement emphasize?
The program encourages identifying molecular signatures (genomic, proteomic, metabolic, epigenetic) that may explain symptoms and help subgroup patients based on underlying biology.
Are studies on comorbidities and population differences encouraged?
Yes. The announcement highlights interest in studying comorbidities and differences by sex or ethnicity.
Can applicants study how GWI affects outcomes for other infections or diseases?
Yes. The opportunity notes interest in evaluating whether GWI changes outcomes for other infections or diseases.
Can the proposed research aim to develop treatments or biomarkers tailored to subtypes of GWI?
Yes. Developing treatments or biomarkers tailored to specific GWI subtypes is included among the emphasized research directions.
What is the optional Biorepository Contribution Option?
The opportunity includes an optional Biorepository Contribution pathway tied to the Boston Biorepository, Recruitment, and Integrative Network (BBRAIN) for GWI. This network was created to retain and share biospecimens and data from Gulf War Veterans for research use.
What does the BBRAIN biorepository contribution involve?
Applicants are encouraged to contribute relevant Veteran biospecimens and/or data to BBRAIN. The option is intended to strengthen shared research infrastructure and increase the long-term value of funded projects for the broader GWI research community.
Does the Biorepository Contribution Option change the funding limit?
Yes. The funding cap is up to $200,000 in direct costs for the full period of performance under the standard Idea Award, or up to $220,000 in direct costs if applying under the Biorepository Contribution Option.
Are there additional submission requirements for the Biorepository Contribution Option?
Yes. This option includes extra submission requirements, including a specific biorepository contribution statement.
What types of projects are explicitly not supported?
The program will not fund studies that treat psychiatric disease or psychological stress as the primary cause of Gulf War Illness. It also does not support applications focused on amyotrophic lateral sclerosis (ALS) as the central topic (with limited allowance described in the announcement). In addition, clinical trials are not allowed under this mechanism.
Is research that frames psychiatric disease or psychological stress as the primary cause of GWI allowed?
No. Studies that treat psychiatric disease or psychological stress as the primary cause of GWI are explicitly not supported by this program.
Are ALS-focused applications allowed?
No, not if ALS is the central topic. However, Gulf War Veterans with ALS may be included if ALS is part of the study's GWI case definition and the work is still fundamentally about GWI symptomatology.
Are clinical trials permitted under the Idea Award?
No. Clinical trials are not allowed under this mechanism.
How does this program define a clinical trial?
For this program, a clinical trial is defined as the prospective assignment of human subjects to interventions (including placebo or controls) to evaluate effects on health outcomes.
If a researcher wants to run a clinical trial, what should they do?
The announcement directs researchers seeking to conduct clinical trials to other GWIRP funding mechanisms designed for that purpose, such as the Clinical Evaluation Award or the Therapeutic/Biomarker Trial Award.
What type of award instrument will be used?
Awards are issued as federal assistance agreements, meaning they can be either grants or cooperative agreements.
What is the difference between a grant and a cooperative agreement in this opportunity?
If the Department of Defense anticipates no substantial involvement during the project, a standard grant is used. If substantial involvement is expected (such as collaboration or participation in aspects of the research), a cooperative agreement is used, and the involvement is specified in the award terms.
What is the maximum amount of funding available?
The funding limit is capped at $200,000 in direct costs for the full period of performance, or up to $220,000 in direct costs with the Biorepository Contribution Option.
How many awards were anticipated?
The program anticipated making about one award.
What was the estimated total funding available for this opportunity?
The estimated total allotment was about $0.32 million.
When were awards expected to be made?
Awards were expected to be made by September 30, 2022.
Who administered this funding opportunity?
The opportunity was administered by the Department of Defense, Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA).
What is the funding opportunity number?
The funding opportunity number is W81XWH-21-GWIRP-IA.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning it is open to any entity type, subject to any additional eligibility notes in the full announcement.
What was the application closing date listed for this opportunity?
The original application closing date was August 19, 2021.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: CDMRP PRMRP Clinical Trial Award
Previous opportunity: Countering Disinformation for Telugu TV Reporters
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 21 GWIRP IA
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 21 GWIRP IA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Gulf War Illness, Clinical Evaluation Award Apply for W81XWH 21 GWIRP CEA Funding Number: W81XWH 21 GWIRP CEA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness, Research Advancement Award Apply for W81XWH 21 GWIRP RAA Funding Number: W81XWH 21 GWIRP RAA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness, Therapeutic/Biomarker Trial Award Apply for W81XWH 21 GWIRP TBTA Funding Number: W81XWH 21 GWIRP TBTA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Gulf War Illness, New Investigator Award Apply for W81XWH 21 GWIRP NIA Funding Number: W81XWH 21 GWIRP NIA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Identifying and Applying Engineering With Nature® (EWN) Solutions to Inland Locations of the Central United States Apply for W81EWF 21 SOI 0010 Funding Number: W81EWF 21 SOI 0010 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $750,000 |
| Digital Connectivity and Cybersecurity Partnership (DCCP) - Pacific Apply for 72088721 PACIFIC RFI 00001 Funding Number: 72088721 PACIFIC RFI 00001 Agency: Agency for International Development, Philippines USAID-Manila Category: Science and Technology and other Research and Development Funding Amount: $19,000,000 |
| Space Domain Awareness Grand Challenge – Ground-Based Spectral Signatures of Satellites Apply for USAFA BAA 2021 CALL0002 Funding Number: USAFA BAA 2021 CALL0002 Agency: Department of Defense, Air Force Academy Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| Disability and Rehabilitation Research Projects (DRRP) Program: Disability and Pregnancy Apply for HHS 2021 ACL NIDILRR DPHF 0059 Funding Number: HHS 2021 ACL NIDILRR DPHF 0059 Agency: Department of Health and Human Services, Administration for Community Living Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| Disability and Rehabilitation Research Projects (DRRP) Program: Model Systems Knowledge Translation Center (MSKTC) Apply for HHS 2021 ACL NIDILRR DPKT 0062 Funding Number: HHS 2021 ACL NIDILRR DPKT 0062 Agency: Department of Health and Human Services, Administration for Community Living Category: Science and Technology and other Research and Development Funding Amount: $792,000 |
| U.S. Nuclear Regulatory Commission Funding Opportunity Announcement (FOA), Research and Development Grant, Fiscal Year (FY) 2021 Apply for 31310021K0002 Funding Number: 31310021K0002 Agency: Nuclear Regulatory Commission Category: Science and Technology and other Research and Development Funding Amount: $500,000 |
| CDMRP PRMRP Investigator Initiated Research Award Apply for W81XWH 21 PRMRP IIRA Funding Number: W81XWH 21 PRMRP IIRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| CDMRP PRMRP Discovery Award Apply for W81XWH 21 PRMRP DA Funding Number: W81XWH 21 PRMRP DA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| CDMRP PRMRP Technology/Therapeutic Development Award Apply for W81XWH 21 PRMRP TTDA Funding Number: W81XWH 21 PRMRP TTDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| CDMRP PRMRP Clinical Trial Award Apply for W81XWH 21 PRMRP CTA Funding Number: W81XWH 21 PRMRP CTA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| CDMRP PRMRP Focused Program Award Apply for W81XWH 21 PRMRP FPA Funding Number: W81XWH 21 PRMRP FPA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| ARPA-E AND ENVIRONMENTAL SECURITY TECHNOLOGY CERTIFICATION PROGRAM DEMONSTRATION PARTNERSHIP 2.0 Apply for DE FOA 0002492 Funding Number: DE FOA 0002492 Agency: Department of Energy, Advanced Research Projects Agency Energy Category: Science and Technology and other Research and Development Funding Amount: $2,000,000 |
| FY2021 Research Opportunities in Accelerator Stewardship Apply for DE FOA 0002463 Funding Number: DE FOA 0002463 Agency: Department of Energy - Office of Science, Office of Science Category: Science and Technology and other Research and Development Funding Amount: $3,000,000 |
| DOE Traineeship in Accelerator Science and Engineering Apply for DE FOA 0002489 Funding Number: DE FOA 0002489 Agency: Department of Energy - Office of Science, Office of Science Category: Science and Technology and other Research and Development Funding Amount: $4,950,000 |
| Broadening Participation in Computing Apply for 21 571 Funding Number: 21 571 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: $1,200,000 |
| NSF Convergence Accelerator Phases I and II for the 2021 Cohort Apply for 21 572 Funding Number: 21 572 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 21 GWIRP IA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.